Treatment with eribulin in HER2-negative breast cancer patients with brain metastases: Experience at Vall d' Hebron University Hospital. (April 2018) - Garrigós, L.; Ortiz, C.; Ruiz-Pace, F.; Arumi, M.; Bellet, M.; Capelan, M.; Escrivá, S.I.; Gomez, P.; Muñoz, E.; Oliveira, M.; Rojas, B.; Zamora, E.; et al.